Profile data is unavailable for this security.
About the company
I'rom Group Co.,Ltd. is engaged in medical fields such as regenerative medicine and gene discovery. The Company operates through four business segments. The SMO segment provides support services for contracting or substituting a part of the work related to conducting clinical trials from the conducting medical institution. The CRO segment provides all or part of clinical trial operations from pharmaceutical companies and others. The Advanced Medicinal Treatment segment is engaged in the development of gene therapy products, the development, manufacture and sale of products in the field of regenerative medicine based on iPS cells related technologies, as well as the provision of contract manufacture services. The Medical Support segment provides general and comprehensive support for medical business management, such as setting up and renting clinic malls, selling products and related services. The Company also provides business utilizing IT infrastructure.
- Revenue in JPY (TTM)17.74bn
- Net income in JPY1.42bn
- Incorporated1997
- Employees894.00
- LocationI'rom Group Co Ltd5F/6FIidabashi Grand Bloom, 2-10-2, FujimiCHIYODA-KU 102-0071JapanJPN
- Phone+81 332643148
- Fax+81 332643147
- Websitehttps://www.iromgroup.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As Partners Co Ltd | 17.15bn | 563.57m | 7.04bn | 835.00 | 12.03 | 2.85 | 12.41 | 0.4105 | 164.64 | 164.64 | 5,010.38 | 695.30 | -- | -- | -- | -- | -- | -- | -- | -- | 18.13 | -- | 3.29 | -- | 0.8768 | 15.56 | 0.7039 | -- | 34.17 | -- | 145.34 | -- | -- | -- |
| Care Twentyone Corp | 42.07bn | -38.76m | 7.42bn | 5.91k | -- | 1.26 | 4.91 | 0.1764 | -2.87 | -2.87 | 3,121.08 | 395.28 | 1.17 | 749.33 | 7.53 | 7,123,649.00 | -0.1224 | 1.48 | -0.1735 | 1.96 | 21.66 | 22.97 | -0.1044 | 1.43 | 1.03 | -0.8588 | 0.7857 | 37.34 | 7.03 | 7.89 | -99.02 | -50.66 | 24.66 | 9.43 |
| Uchiyama Holdings Co Ltd | 28.84bn | 213.92m | 7.48bn | 2.33k | 31.29 | 0.5419 | 8.79 | 0.2593 | 11.06 | 11.06 | 1,490.07 | 638.54 | 0.9427 | 102.32 | 11.39 | -- | 0.6992 | -2.04 | 0.9815 | -2.76 | 7.29 | 5.43 | 0.7417 | -2.27 | 1.59 | 22.36 | 0.5216 | -- | 7.18 | 1.17 | 153.40 | -27.96 | -9.99 | 0.00 |
| Advantage Risk Management Co., Ltd. | 7.00bn | 505.58m | 8.78bn | 391.00 | 16.77 | 2.13 | 12.83 | 1.25 | 30.29 | 30.29 | 419.43 | 238.51 | 1.12 | -- | 6.76 | -- | 8.09 | 7.72 | 12.38 | 12.15 | 70.49 | 74.07 | 7.22 | 7.42 | -- | -- | 0.0797 | 40.08 | 9.26 | 7.40 | 33.89 | -3.84 | 36.78 | 3.71 |
| Japan Hospice Holdings Inc | 10.35bn | 669.37m | 12.30bn | 963.00 | 18.21 | 4.20 | 11.10 | 1.19 | 82.06 | 82.06 | 1,267.69 | 355.74 | 0.7351 | -- | 6.88 | 10,749,690.00 | 4.75 | 4.43 | 5.42 | 5.29 | 18.15 | 19.68 | 6.47 | 5.49 | -- | 3.27 | 0.7868 | 0.00 | 25.05 | 26.77 | 49.95 | 35.47 | 87.38 | -- |
| StemCell Institute Inc | 2.48bn | 310.98m | 16.65bn | 92.00 | 53.54 | 6.18 | 48.62 | 6.71 | 30.35 | 30.35 | 242.15 | 262.78 | 0.4017 | 22.19 | 1.82 | -- | 5.03 | 4.23 | 12.05 | 10.85 | 63.51 | 64.40 | 12.53 | 10.41 | 1.19 | -- | 0.0033 | 0.00 | 18.64 | 16.63 | 57.04 | 16.84 | 46.68 | -- |
| CellSource Co Ltd | 4.57bn | 813.06m | 24.18bn | 151.00 | 29.32 | 3.97 | 26.59 | 5.29 | 41.65 | 41.65 | 232.98 | 307.83 | 0.7816 | 6.43 | 11.51 | 30,249,040.00 | 13.91 | 19.23 | 15.46 | 22.57 | 67.15 | 70.75 | 17.80 | 20.21 | 9.12 | -- | 0.00 | 12.89 | 5.54 | 30.04 | -9.30 | 36.70 | 70.54 | -- |
| Falco Holdings Co Ltd | 43.01bn | 1.67bn | 25.46bn | 1.16k | 15.19 | 0.9424 | 12.70 | 0.592 | 151.32 | 151.32 | 3,894.77 | 2,438.54 | 1.14 | 20.60 | 6.67 | -- | 4.43 | 5.79 | 5.75 | 7.95 | 30.05 | 31.28 | 3.88 | 4.66 | 2.29 | -- | 0.0304 | 30.17 | -8.33 | -0.5259 | -26.32 | 20.60 | 0.8937 | 11.70 |
| I'rom Group Co Ltd | 17.74bn | 1.42bn | 34.40bn | 894.00 | 23.86 | 2.64 | 19.16 | 1.94 | 116.87 | 116.87 | 1,465.20 | 1,054.90 | 0.4909 | 13.33 | 5.02 | -- | 3.92 | 6.94 | 5.97 | 9.87 | 42.31 | 43.17 | 7.98 | 11.34 | 1.18 | -- | 0.6098 | 29.64 | -3.33 | 10.89 | -44.34 | 9.18 | 16.61 | 14.87 |
| CUC Inc | 33.02bn | 2.60bn | 40.31bn | 2.99k | 15.09 | 1.44 | 9.13 | 1.22 | 89.09 | 89.09 | 1,135.93 | 931.80 | 0.6438 | 294.86 | 3.89 | -- | 5.08 | -- | 7.24 | -- | 48.21 | -- | 7.90 | -- | 2.09 | -- | 0.4883 | -- | -6.21 | -- | 7.10 | -- | -- | -- |
| Gakken Holdings Co Ltd | 176.45bn | 3.73bn | 44.86bn | 9.49k | 11.81 | 0.8085 | 5.70 | 0.2542 | 85.07 | 85.07 | 4,026.33 | 1,243.07 | 1.30 | 9.95 | 6.40 | 18,592,940.00 | 3.10 | 2.61 | 4.87 | 3.99 | 28.10 | 29.17 | 2.38 | 1.95 | 1.15 | 16.99 | 0.4373 | 33.86 | 5.18 | 8.93 | -7.15 | 0.8741 | -7.84 | 7.39 |
| Charm Care Corp | 44.99bn | 3.93bn | 52.57bn | 2.00k | 13.39 | 3.22 | 10.92 | 1.17 | 120.02 | 120.02 | 1,375.72 | 499.01 | 0.9959 | 4.49 | 15.23 | 22,537,580.00 | 8.69 | 7.13 | 16.95 | 10.72 | 18.01 | 17.38 | 8.73 | 7.86 | 0.7114 | 104.06 | 0.5086 | 20.33 | 30.32 | 22.79 | 8.62 | 39.09 | 16.02 | 54.49 |
| Sunwels Co Ltd | 21.36bn | 2.03bn | 97.74bn | 1.75k | 41.51 | 11.75 | 48.46 | 4.58 | 66.85 | 66.85 | 702.80 | 236.17 | 0.8421 | 1,154.05 | 6.41 | -- | 8.02 | -- | 10.23 | -- | 30.07 | -- | 9.52 | -- | 0.9693 | 5.50 | 0.7379 | -- | 55.72 | -- | 159.16 | -- | -- | -- |
Data as of Jun 14 2024. Currency figures normalised to I'rom Group Co Ltd's reporting currency: Japanese Yen JPY
5.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 May 2024 | 252.50k | 2.05% |
| Nikko Asset Management Co., Ltd.as of 07 Jun 2024 | 121.10k | 0.98% |
| Daiwa Asset Management Co. Ltd.as of 30 Apr 2024 | 115.20k | 0.93% |
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 95.40k | 0.77% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 2024 | 49.80k | 0.40% |
| BlackRock Japan Co. Ltd.as of 06 Jun 2024 | 14.80k | 0.12% |
| Asset Management One Co., Ltd.as of 06 Jun 2024 | 12.20k | 0.10% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 2024 | 11.50k | 0.09% |
| American Century Investment Management, Inc.as of 06 Jun 2024 | 10.50k | 0.09% |
| Dimensional Fund Advisors Ltd.as of 06 Jun 2024 | 3.78k | 0.03% |
More ▼
Data from 31 Mar 2024 - 13 Jun 2024Source: FactSet Research Systems Inc.
